{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:10:19Z","timestamp":1770840619099,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Cultivation Foundation of The Second Hospital of Shandong University","award":["2023YP19"],"award-info":[{"award-number":["2023YP19"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02163-z","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:24:15Z","timestamp":1768814655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ensemble learning strategy-based 18\u00a0F-FDG PET\/CT metabolic habitats radiomics for predicting EGFR mutation and prognosis in LA-NSCLC: a multi-center study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yu","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juntao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengjun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8510-0275","authenticated-orcid":false,"given":"Jingsong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3430-4817","authenticated-orcid":false,"given":"Dexin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"2163_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2025.01.001","author":"H Zhou","year":"2025","unstructured":"Zhou H, Zheng Z, Fan C, Zhou Z. Mechanisms and strategies of Immunosenescence effects on non-small cell lung cancer (NSCLC) treatment: A comprehensive analysis and future directions. Semin Cancer Biol. 2025. https:\/\/doi.org\/10.1016\/j.semcancer.2025.01.001.","journal-title":"Semin Cancer Biol"},{"key":"2163_CR2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01162","author":"JD Bradley","year":"2020","unstructured":"Bradley JD, Hu C, Komaki RR, et al. Long-Term results of NRG oncology RTOG 0617: Standard- versus High-Dose chemoradiotherapy with or without cetuximab for unresectable stage III Non-Small-Cell lung cancer. J Clin Oncol. 2020. https:\/\/doi.org\/10.1200\/JCO.19.01162.","journal-title":"J Clin Oncol"},{"key":"2163_CR3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01639","author":"JA Bogart","year":"2022","unstructured":"Bogart JA, Waqar SN, Mix MD. Radiation and systemic therapy for Limited-Stage Small-Cell lung cancer. J Clin Oncol. 2022. https:\/\/doi.org\/10.1200\/JCO.21.01639.","journal-title":"J Clin Oncol"},{"key":"2163_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00971-2","author":"F Zhou","year":"2025","unstructured":"Zhou F, Guo H, Xia Y, et al. The changing treatment landscape of EGFR-mutant non-small-cell lung cancer. Nat Rev Clin Oncol. 2025. https:\/\/doi.org\/10.1038\/s41571-024-00971-2.","journal-title":"Nat Rev Clin Oncol"},{"key":"2163_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00379-6","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, He Y, Wang W, et al. Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis. Lancet Oncol. 2024. https:\/\/doi.org\/10.1016\/S1470-2045(24)00379-6.","journal-title":"Lancet Oncol"},{"key":"2163_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jamaoncol.2023.5276","volume":"10","author":"HJ West","year":"2024","unstructured":"West HJ, Kim JY. Rapid advances in resectable Non-Small cell lung cancer: A narrative review. JAMA Oncol. 2024;10:249\u201355. https:\/\/doi.org\/10.1001\/jamaoncol.2023.5276.","journal-title":"JAMA Oncol"},{"key":"2163_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04592-1","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zhao X, Zhao Y, et al. Value of pre-therapy 18F-FDG PET\/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2020. https:\/\/doi.org\/10.1007\/s00259-019-04592-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2163_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00566-0","author":"A Friedlaender","year":"2024","unstructured":"Friedlaender A, Perol M, Banna GL, et al. Oncogenic alterations in advanced NSCLC: a molecular super-highway. Biomark Res. 2024. https:\/\/doi.org\/10.1186\/s40364-024-00566-0.","journal-title":"Biomark Res"},{"key":"2163_CR9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02417","author":"AJ Piper Vallillo","year":"2024","unstructured":"Piper Vallillo AJ, Viray H, Feldman J, Rangachari D. Management of treatment resistance in patients with advanced epidermal growth factor Receptor-Mutated lung cancer: Personalization, Parsimony, and partnership. J Clin Oncol. 2024. https:\/\/doi.org\/10.1200\/JCO.23.02417.","journal-title":"J Clin Oncol"},{"key":"2163_CR10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00986-2018","author":"S Wang","year":"2019","unstructured":"Wang S, Shi J, Ye Z, et al. Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning. Eur Respir J. 2019. https:\/\/doi.org\/10.1183\/13993003.00986-2018.","journal-title":"Eur Respir J"},{"key":"2163_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2021.09.003","author":"C Aggarwal","year":"2021","unstructured":"Aggarwal C, Bubendorf L, Cooper WA, et al. Molecular testing in stage I-III non-small cell lung cancer: approaches and challenges. Lung Cancer. 2021. https:\/\/doi.org\/10.1016\/j.lungcan.2021.09.003.","journal-title":"Lung Cancer"},{"key":"2163_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00985-w","author":"N Normanno","year":"2025","unstructured":"Normanno N, Morabito A, Rachiglio AM, et al. Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation? Nat Rev Clin Oncol. 2025. https:\/\/doi.org\/10.1038\/s41571-024-00985-w.","journal-title":"Nat Rev Clin Oncol"},{"key":"2163_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102791","author":"A Marinello","year":"2024","unstructured":"Marinello A, Tagliamento M, Pagliaro A, et al. Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer. Cancer Treat Rev. 2024. https:\/\/doi.org\/10.1016\/j.ctrv.2024.102791.","journal-title":"Cancer Treat Rev"},{"key":"2163_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.240","author":"Y Gan","year":"2010","unstructured":"Gan Y, Shi C, Inge L, et al. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Oncogene. 2010. https:\/\/doi.org\/10.1038\/onc.2010.240.","journal-title":"Oncogene"},{"key":"2163_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01062","author":"X Li","year":"2019","unstructured":"Li X, Yin G, Zhang Y, et al. Predictive power of a radiomic signature based on 18F-FDG PET\/CT images for EGFR mutational status in NSCLC. Front Oncol. 2019. https:\/\/doi.org\/10.3389\/fonc.2019.01062.","journal-title":"Front Oncol"},{"key":"2163_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-008-9160-1","author":"C-T Huang","year":"2010","unstructured":"Huang C-T, Yen R-F, Cheng M-F, et al. Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma. Med Oncol. 2010. https:\/\/doi.org\/10.1007\/s12032-008-9160-1.","journal-title":"Med Oncol"},{"key":"2163_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3885-z","author":"Z Lv","year":"2018","unstructured":"Lv Z, Fan J, Xu J, et al. Value of (18)F-FDG PET\/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients. Eur J Nucl Med Mol Imaging. 2018. https:\/\/doi.org\/10.1007\/s00259-017-3885-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2163_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000000975","author":"SM Lee","year":"2015","unstructured":"Lee SM, Bae SK, Jung SJ, Kim CK. FDG uptake in non-small cell lung cancer is not an independent predictor of EGFR or KRAS mutation status: a retrospective analysis of 206 patients. Clin Nucl Med. 2015. https:\/\/doi.org\/10.1097\/RLU.0000000000000975.","journal-title":"Clin Nucl Med"},{"key":"2163_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2024.06.038","author":"R Hinzpeter","year":"2024","unstructured":"Hinzpeter R, Kulanthaivelu R, Kohan A, et al. Predictive [(18)F]-FDG PET\/CT-Based radiogenomics modelling of driver gene mutations in Non-small cell lung cancer. Acad Radiol. 2024. https:\/\/doi.org\/10.1016\/j.acra.2024.06.038.","journal-title":"Acad Radiol"},{"key":"2163_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.894323","author":"L Yang","year":"2022","unstructured":"Yang L, Xu P, Li M, et al. PET\/CT radiomic features: A potential biomarker for EGFR mutation status and survival outcome prediction in NSCLC patients treated with TKIs. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.894323.","journal-title":"Front Oncol"},{"key":"2163_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000001948","author":"Y Fan","year":"2025","unstructured":"Fan Y, Liu Y, Ouyang X, et al. Prediction of EGFR mutation status and its subtypes in non-small cell lung cancer based on 18F-FDG PET\/CT radiological features. Nucl Med Commun. 2025. https:\/\/doi.org\/10.1097\/MNM.0000000000001948.","journal-title":"Nucl Med Commun"},{"key":"2163_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-022-09055-0","author":"J Li","year":"2022","unstructured":"Li J, Qiu Z, Zhang C, et al. ITHscore: comprehensive quantification of intra-tumor heterogeneity in NSCLC by multi-scale radiomic features. Eur Radiol. 2022. https:\/\/doi.org\/10.1007\/s00330-022-09055-0.","journal-title":"Eur Radiol"},{"key":"2163_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2024.12.038","author":"B-H Xue","year":"2025","unstructured":"Xue B-H, Chen S-L, Lan J-P, et al. Explainable PET-Based habitat and peritumoral machine learning model for predicting Progression-free survival in clinical stage IA Pure-Solid Non-small cell lung cancer: A Two-center study. Acad Radiol. 2025. https:\/\/doi.org\/10.1016\/j.acra.2024.12.038.","journal-title":"Acad Radiol"},{"key":"2163_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47512-0","author":"SJ Sujit","year":"2024","unstructured":"Sujit SJ, Aminu M, Karpinets TV, et al. Enhancing NSCLC recurrence prediction with PET\/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights. Nat Commun. 2024. https:\/\/doi.org\/10.1038\/s41467-024-47512-0.","journal-title":"Nat Commun"},{"key":"2163_CR25","doi-asserted-by":"publisher","DOI":"10.21037\/qims-20-1182","author":"H Shen","year":"2021","unstructured":"Shen H, Chen L, Liu K, et al. A subregion-based positron emission tomography\/computed tomography (PET\/CT) radiomics model for the classification of non-small cell lung cancer histopathological subtypes. Quant Imaging Med Surg. 2021. https:\/\/doi.org\/10.21037\/qims-20-1182.","journal-title":"Quant Imaging Med Surg"},{"key":"2163_CR26","doi-asserted-by":"publisher","DOI":"10.62347\/DDRR4923","author":"Y Wang","year":"2024","unstructured":"Wang Y. Subregion-specific 18F-FDG PET-CT radiomics for the pre-treatment prediction of EGFR mutation status in solid lung adenocarcinoma. Am J Nucl Med Mol Imaging. 2024. https:\/\/doi.org\/10.62347\/DDRR4923.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"2163_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04904-6","author":"J Peng","year":"2024","unstructured":"Peng J, Zou D, Zhang X, et al. A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma. J Transl Med. 2024. https:\/\/doi.org\/10.1186\/s12967-024-04904-6.","journal-title":"J Transl Med"},{"key":"2163_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13206-5","author":"C Sui","year":"2024","unstructured":"Sui C, Su Q, Chen K, et al. (18)F-FDG PET\/CT-based habitat radiomics combining stacking ensemble learning for predicting prognosis in hepatocellular carcinoma: a multi-center study. BMC Cancer. 2024. https:\/\/doi.org\/10.1186\/s12885-024-13206-5.","journal-title":"BMC Cancer"},{"key":"2163_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-025-02948-z","author":"X Lin","year":"2025","unstructured":"Lin X, Liu Z, Zhou K, et al. Intratumoral and peritumoral PET\/CT-based radiomics for non-invasively and dynamically predicting immunotherapy response in NSCLC. Br J Cancer. 2025. https:\/\/doi.org\/10.1038\/s41416-025-02948-z.","journal-title":"Br J Cancer"},{"key":"2163_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-025-00751-6","author":"S Li","year":"2025","unstructured":"Li S, Kendrick J, Ebert MA, et al. Auto-segmentation, radiomic reproducibility, and comparison of radiomics between manual and AI-derived segmentations for coronary arteries in cardiac [18F]NaF PET\/CT images. EJNMMI Phys. 2025. https:\/\/doi.org\/10.1186\/s40658-025-00751-6.","journal-title":"EJNMMI Phys"},{"key":"2163_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108827","author":"A Stefano","year":"2024","unstructured":"Stefano A. Challenges and limitations in applying radiomics to PET imaging: possible opportunities and avenues for research. Comput Biol Med. 2024. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108827.","journal-title":"Comput Biol Med"},{"key":"2163_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s10278-024-01281-w","author":"G Pasini","year":"2025","unstructured":"Pasini G, Stefano A, Mantarro C, et al. A robust [18F]-PSMA-1007 radiomics ensemble model for prostate cancer risk stratification. J Imaging Inf Med. 2025. https:\/\/doi.org\/10.1007\/s10278-024-01281-w.","journal-title":"J Imaging Inf Med"},{"key":"2163_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.759897","author":"L Chen","year":"2021","unstructured":"Chen L, Liu K, Zhao X, et al. Habitat imaging-based 18F-FDG PET\/CT radiomics for the preoperative discrimination of non-small cell lung cancer and benign inflammatory diseases. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.759897.","journal-title":"Front Oncol"},{"key":"2163_CR34","doi-asserted-by":"publisher","DOI":"10.1109\/TSMC.1979.4310076","author":"N Otsu","year":"2007","unstructured":"Otsu N. A threshold selection method from Gray-Level histograms. IEEE Trans Syst Man Cybernetics. 2007. https:\/\/doi.org\/10.1109\/TSMC.1979.4310076.","journal-title":"IEEE Trans Syst Man Cybernetics"},{"key":"2163_CR35","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad543","author":"Y Fu","year":"2024","unstructured":"Fu Y, Wang X, Yi X, et al. Ensemble machine learning model incorporating radiomics and body composition for predicting intraoperative HDI in PPGL. J Clin Endocrinol Metab. 2024. https:\/\/doi.org\/10.1210\/clinem\/dgad543.","journal-title":"J Clin Endocrinol Metab"},{"key":"2163_CR36","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.265244","author":"S Zhao","year":"2023","unstructured":"Zhao S, Wang J, Jin C, et al. Stacking ensemble Learning-Based [(18)F]FDG PET radiomics for outcome prediction in diffuse large B-Cell lymphoma. J Nucl Med. 2023. https:\/\/doi.org\/10.2967\/jnumed.122.265244.","journal-title":"J Nucl Med"},{"key":"2163_CR37","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/54\/24\/007","author":"C Liu","year":"2009","unstructured":"Liu C, Pierce LA 2nd, Alessio AM, Kinahan PE. The impact of respiratory motion on tumor quantification and delineation in static PET\/CT imaging. Phys Med Biol. 2009. https:\/\/doi.org\/10.1088\/0031-9155\/54\/24\/007.","journal-title":"Phys Med Biol"},{"key":"2163_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115510","author":"S Yip","year":"2014","unstructured":"Yip S, McCall K, Aristophanous M, Chen AB, Aerts HJ, Berbeco R. Comparison of texture features derived from static and respiratory-gated PET images in non-small cell lung cancer. PLoS ONE. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0115510.","journal-title":"PLoS ONE"},{"key":"2163_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.10.005","author":"S Wang","year":"2020","unstructured":"Wang S, Ma P, Ma G, et al. Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis. Eur J Cancer. 2020. https:\/\/doi.org\/10.1016\/j.ejca.2019.10.005.","journal-title":"Eur J Cancer"},{"key":"2163_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(22)00024-3","author":"S Wang","year":"2022","unstructured":"Wang S, Yu H, Gan Y, et al. Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study. Lancet Digit Health. 2022. https:\/\/doi.org\/10.1016\/S2589-7500(22)00024-3.","journal-title":"Lancet Digit Health"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02163-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02163-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02163-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:21:21Z","timestamp":1770837681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02163-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2163"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02163-z","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"11 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committees of Shandong Cancer Hospital and Institute, and The Second hospital of Shandong University (No. KYLL2024487). This article does not contain any experiments with animals. Due to the retrospective nature of the study, informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}